The gap between your regulatory submission and your commercial catalog is where your next inspection finding lives.
Pharmaceutical and medical device companies invest hundreds of millions in clinical trials, GMP-certified manufacturing, and pharmacovigilance systems — and then distribute product information through spreadsheets, shared drives, and disconnected commercial databases. Brandhubify closes that gap: a single, AI-powered platform where regulatory-approved product data becomes the auditable, version-controlled source for every commercial channel, every GPO submission, every global market, and every regulatory filing — simultaneously.
The status quo
Sound familiar?
These are the friction points we hear from healthcare & medical devices teams, week after week.
Your NDA/BLA submission and your commercial catalog are two living documents. They are rarely identical. That delta is your inspection exposure.
The product attributes your regulatory team submits in an NDA, BLA, or 510(k) must align exactly with what your commercial team is publishing to GPO portals, hospital procurement systems, and channel partners worldwide. A labeling discrepancy is not a data quality issue — it is a pharmacovigilance failure and a potential 21 CFR Part 11 deviation. FDA inspectors cross-reference commercial content against submission data. The gap between your two systems is where they find observations.
A single outdated indication-for-use in a GPO listing is not a content error. It is a REMS violation waiting to be triggered at the point of patient care.
When an incorrect device classification, a superseded contraindication, or a wrong UDI identifier reaches a hospital procurement system, the clinical staff making real-time purchasing decisions are working from wrong information. In pharmaceuticals and medical devices, that is not a CRM problem to fix in the next sprint. That is a Risk Evaluation and Mitigation Strategy (REMS) failure, a 483 observation, or a Class II recall trigger — depending on the product category and the jurisdiction in which it surfaces.
Regulatory Affairs, Medical Affairs, and Commercial Excellence are each managing the same product from three disconnected systems. The reconciliation is manual. The risk is structural.
Regulatory Affairs owns the submission dossier and labeling master. Medical Affairs manages indication content, clinical messaging, and post-market surveillance data. Commercial Excellence syndicates to GPO portals, IDN procurement systems, and global channel partners. Each team is operating from a different version of what should be a single, authoritative product record. The delta between those three systems is where your inspection risk accumulates, your labeling inconsistency propagates, and your post-market pharmacovigilance gaps become SAE reporting failures.
The Brandhubify approach
How Brandhubify works for Healthcare & Medical Devices
Each capability is purpose-built — working together as one connected platform.
21 CFR Part 11 and MDR-compliant electronic audit trail — built in, not built for
Every attribute change, every approval, and every version transition is timestamped, attributed to a named user, electronically signed, and permanently version-locked. Brandhubify reconstructs the exact state of any product record — at the field level — at any point in its regulatory lifecycle. The data your submission referenced eighteen months ago is preserved, untouched, permanently retrievable. When an FDA inspector or MDR compliance authority requests documentation, your team provides it in minutes — not days.
21 CFR Part 11-compliant electronic audit trail — out of the box, zero custom development, zero IT build time.
Audit Trail
Tamper-evident · Full record history
J. Chen
10:42 AM
Updated classification
Device Class: IIb
M. Patel
09:15 AM
Added certification
CE Mark attached
System
Yesterday
Version locked
v2.4 → Regulatory
R. Okafor
Mon
Approved record
Reg. sign-off
Record Version Locked
v2.4 · Submitted to regulatory body · Cannot be modified
Regulatory-locked data governance — commercial velocity without compliance exposure
Regulatory Affairs controls the master product record, field by field, attribute by attribute. Commercial, Medical Affairs, and marketing publish from the approved record — never to it without a formal change control workflow. Changes to device classification, indication for use, contraindications, dosage, and labeling text trigger a mandatory approval cycle that mirrors your internal SOPs — enforced structurally, not by individual vigilance. Your compliance posture does not depend on who remembered to check before clicking publish.
Unauthorized edits to regulated attributes become architecturally impossible — not policy-prohibited. The system IS the SOP.
Approval Chain
Record: REG-DEV-2401 — 2 of 5 approved
Regulatory
Data Entry & Classification
Compliance
Attribute Review & Sign-off
Legal
Regulatory Check
Quality Assurance
QA Sign-off
Commercial
Release Approval
Submission-matched version locking — your regulatory record, permanently preserved through every commercial lifecycle stage
When a product record achieves regulatory approval, it is locked to that exact version — immutably. Every downstream commercial channel, GPO submission, IDN portal, and global market listing publishes from that version. Future commercial edits require a new formal change control cycle, producing a new approved version. The record your submission referenced is never overwritten, never archived away, never lost in a system migration. It exists — intact, fully auditable, permanently linked to the submission it supported — for the life of the product and beyond.
Complete regulatory continuity through every commercial change, every product lifecycle stage, every market — without manual version management or IT intervention.
Record History
MDR-DEV-4201 · Tamper-evident version control
Jan 14
Feb 03
Mar 12
Draft
v3.0 is the regulatory reference — commercial edits branch as v4.x
—Regulatory Affairs Infrastructure—
Your regulatory infrastructure is only as strong as the data layer underneath it. Brandhubify is that layer.
Pharmaceutical and medical device companies have built world-class regulatory functions — submission teams, labeling specialists, global regulatory strategy directors. Brandhubify gives those functions the governed, auditable product data layer they have always needed but never had: a single system where regulatory approval is the gate that product data must pass before it can reach any commercial channel, in any market, globally.
CTD, eCTD, and EUDAMED-structured export — directly from your system of record, with zero transcription risk
Export product records in FDA eCTD, ICH CTD, MDR Annex II, or EUDAMED-compatible structured formats directly from Brandhubify — with the exact field mapping and nomenclature your submission requires. The data your regulatory affairs team submits to FDA or EMA is drawn from the same record your commercial team publishes globally. There is no transcription step between your internal system and your submission package. There is no opportunity for the two versions to diverge. What the inspector reads matches what the market sees. Structurally, not by process.
Explore featureChange control enforcement at the attribute level — your SOPs in the data model, not in a training deck
Lock regulated attributes — device classification, indication for use, contraindications, UDI data, REMS-relevant fields, and labeling text — at the field level following regulatory sign-off. Any subsequent edit to a locked attribute triggers a mandatory formal change control workflow: assignable review steps, electronic sign-off, timestamped approval, and version increment. Your GMP change control requirements are enforced by the system — not by a reminder in a quality training deck. The SOP compliance rate is 100%, because the system does not allow another option.
Explore featureSubmission deadlines, CE certificate expiry, and reauthorization windows — tracked across your full portfolio, automatically
Track NDA/BLA approval anniversary dates, 510(k) resubmission windows, MDR renewal deadlines, EUDAMED registration expiry, and CE certificate validity periods — across every SKU, every market, every certification body — in a single live view. Brandhubify surfaces compliance gaps automatically and routes alerts to the responsible regulatory manager before a certificate lapses, before a resubmission window closes, before an inspection finds the gap first.
Explore feature—Quality, Safety & Pharmacovigilance—
A product data error in healthcare is not a content problem. It is a pharmacovigilance event, a CAPA trigger, and a patient safety obligation — simultaneously.
Your pharmacovigilance and QA teams operate under ICH E2E guidelines, GVP modules, and post-market clinical follow-up requirements. Those obligations are only met if the product data feeding your commercial channels matches the safety data in your pharmacovigilance database. Brandhubify is the governance layer that ensures they always do — and provides the audit evidence to prove it when an authority asks.
Four-eyes principle on safety-critical attributes — enforced structurally, with electronic sign-off that satisfies GMP audit requirements
Require a second qualified reviewer — including a named QA signatory — for changes to safety-critical attributes: indication for use, contraindications, device classification, dosage form, REMS-designated fields, and labeling content. The four-eyes requirement is not a policy your team can forget under deadline pressure. It is a system control. The approval record — both reviewers, both timestamps, both electronic signatures — appears in the immutable audit log. Your GMP inspector does not need to interview staff. They read the log.
Pre-publication impact assessment — every affected channel, every active clinical reference, every downstream listing, before a single character goes live
Before any data change publishes, Brandhubify surfaces every channel, every GPO listing, every IDN portal, every market, and every active regulatory or clinical document that references the changed attribute — including any post-market clinical follow-up studies or pharmacovigilance signal databases drawing from the product record. No downstream clinical, commercial, or regulatory impact goes unreviewed before it reaches a clinician's purchasing system.
Device History Record and post-market surveillance data structure — built to satisfy regulatory authority requests, not to satisfy a data field requirement
Maintain a complete, tamper-evident, structured history of every product record — aligned with DHR requirements for medical devices and GVP Module VI requirements for pharmaceutical post-market surveillance. Every edit, every approval, every version transition, and every channel publication event is part of the permanent record. When a regulatory authority initiates a post-market review, when an SAE report triggers a product data audit, or when an IDN procurement committee requests a full product history — Brandhubify provides it, complete and current, in under 30 minutes.
—Commercial Excellence & Market Access—
Your Market Access team is closing GPO contracts and IDN formulary wins. Your product data infrastructure needs to execute at the same speed — without creating compliance exposure.
GPO negotiations, IDN formulary inclusion, specialty pharmacy onboarding, and direct hospital procurement all require product data that is attribute-complete, schema-correct, and provably compliant. The moment your commercial team wins access, Brandhubify executes the data syndication. Your market access opportunity does not wait while someone manually formats a spreadsheet for a procurement system.
GPO portals, IDN procurement systems, and specialty pharmacy networks — pre-connected, with GTIN, GMDN, UDI, and NDC fields pre-mapped
Connect to major Group Purchasing Organization (GPO) portal systems, Integrated Delivery Network (IDN) procurement platforms, and specialty pharmacy networks with pre-built, healthcare-native schemas — including GTIN, GMDN, UDI Device Identifier, NDC code fields, and NPI-linked data attributes. Your Market Access team wins the formulary placement. Brandhubify executes the data submission to the procurement system — with the exact schema each GPO or IDN expects, on the day the contract is signed. No manual reformatting. No IT project. No delay between commercial win and commercial activation.
GUDID-registered UDI management — Device Identifier, Production Identifier, and issuing agency, version-locked to every label and channel listing
Manage all FDA UDI attributes — Device Identifier (DI), Production Identifier (PI), issuing agency (GS1, HIBCC, ICCBBA), GUDID submission status, and associated labeling references — within the product record in Brandhubify. Every commercial channel listing, every GPO data submission, and every label revision carries the correct, GUDID-registered current identifier — automatically, without a manual reconciliation step. UDI compliance is embedded in your product data workflow.
Global regulatory mapping — FDA, EMA, CDSCO, TGA, and PMDA requirements managed in a single product record, output correctly to each market
Manage country-specific regulatory attributes, CE marking details, EUDAMED registration numbers, CDSCO license references, TGA Australian Register of Therapeutic Goods (ARTG) entries, PMDA approval data, and local market labeling requirements — all within a single product record in Brandhubify. At output, the system maps and delivers the correct regulatory version for each market — automatically. Your global regulatory affairs team works from one authoritative record. Your commercial teams in each market publish the correct, locally-compliant version. There is no reconciliation exercise between the two.
—Brandhubify AI—
The first PIM built for pharmaceutical compliance that also thinks.
Brandhubify AI is not a chatbot layered on top of a database. It is an intelligence layer embedded in your product data workflow — trained to understand your regulatory context, flag inconsistencies before they reach a submission or a channel, and generate compliant product content at the speed your commercial organization demands.
AI-powered labeling consistency review — across every SKU, every market, every channel, continuously
Brandhubify AI continuously scans your commercial product content against your approved regulatory labeling master — flagging indication language drift, contraindication omissions, dosage inconsistencies, and UDI reference mismatches before they reach a GPO portal or a hospital procurement system. What your pharmacovigilance team reviews manually in a quarterly content audit, Brandhubify AI monitors in real time, across your full catalog.
Explore featureCompliant product content generation at commercial scale — in your brand voice, within your regulatory guardrails
When your Market Access team needs channel-ready product descriptions for 200 SKUs across 8 GPO portals by end of quarter, Brandhubify AI generates first drafts — using your approved labeling language, your regulatory attribute set, and each channel's specific schema requirements. Your regulatory affairs team reviews, not authors. Your commercial team publishes, not formats. The AI works within the guardrails your regulatory team has set. It does not create content that diverges from approved labeling.
Explore featureRegulatory gap detection — AI that surfaces submission-readiness risks before your team submits, not after a 483
Before a product record is exported for regulatory submission or syndicated to a commercial channel, Brandhubify AI runs a gap detection pass — comparing the current product data state against submission requirements, attribute completeness thresholds, and historical inspection observations in your portfolio. Gaps, inconsistencies, and missing required fields surface as prioritized alerts — with the specific attribute, the specific channel, and the specific regulatory requirement that is at risk. Your team addresses them before submission. Not after a 483.
Explore featureYou have built clinical trial infrastructure, GMP-certified manufacturing, and pharmacovigilance systems that meet the most demanding regulatory standards in the world. Your product data layer should be held to the same standard.
Pharmaceutical and medical device teams achieve 21 CFR Part 11-ready data governance, GPO channel connectivity, and AI-powered content operations in under 30 days — without custom IT development, without a systems integrator engagement, and without disrupting your regulatory team's existing workflows.